Medico Intercontinental Limited (BOM:539938)
India · Delayed Price · Currency is INR 28.72
-0.45 (-1.54%)
At close: Aug 24, 2026
Medico Intercontinental Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 834.41 | 840.84 | 960.15 | 713.55 | 762.26 | 742.6 |
Other Revenue | 11.41 | 12.7 | 2.61 | 1.52 | 2.96 | 1.2 |
| 845.82 | 853.55 | 962.76 | 715.07 | 765.22 | 743.8 | |
Revenue Growth | -14.21% | -11.34% | 34.64% | -6.55% | 2.88% | 6.61% |
Cost of Revenue | 633.04 | 626.54 | 746.15 | 548.77 | 623.13 | 608.51 |
Gross Profit | 212.78 | 227.01 | 216.61 | 166.3 | 142.09 | 135.29 |
Selling, General & Admin | 93.65 | 87.66 | 64.47 | 64.21 | 43.67 | 44.47 |
Other Operating Expenses | 91.58 | 96.89 | 64.37 | 39.91 | 40.69 | 37.51 |
Operating Expenses | 245.43 | 238.82 | 136.9 | 106.97 | 86.37 | 83.99 |
Operating Income | -32.65 | -11.81 | 79.71 | 59.34 | 55.72 | 51.3 |
Interest Expense | -77.13 | -81.59 | -9.67 | -4.8 | -6.11 | -8.65 |
Earnings From Equity Investments | 1.05 | 1.11 | - | - | - | - |
Other Non Operating Income (Expenses) | 0 | 0 | -0.28 | -0.13 | -0.08 | -0.09 |
EBT Excluding Unusual Items | -108.73 | -92.3 | 69.75 | 54.41 | 49.53 | 42.56 |
Impairment of Goodwill | - | - | -0.02 | -0.02 | -0.03 | -0.04 |
Pretax Income | -108.73 | -92.3 | 69.73 | 54.39 | 49.5 | 42.53 |
Income Tax Expense | 16.62 | 17.51 | 19.16 | 14.91 | 13.42 | 11.53 |
Earnings From Continuing Operations | -125.35 | -109.8 | 50.57 | 39.47 | 36.08 | 31 |
Minority Interest in Earnings | 85.65 | 77.8 | - | - | - | - |
Net Income | -39.7 | -32.01 | 50.57 | 39.47 | 36.08 | 31 |
Net Income to Common | -39.7 | -32.01 | 50.57 | 39.47 | 36.08 | 31 |
Net Income Growth | - | - | 28.13% | 9.39% | 16.41% | 20.32% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 6 | 3 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 6 | 3 |
Shares Change | 0.24% | 0.02% | - | 55.51% | 97.92% | - |
EPS (Basic) | -3.97 | -3.20 | 5.06 | 3.95 | 5.61 | 9.54 |
EPS (Diluted) | -3.97 | -3.20 | 5.06 | 3.95 | 5.61 | 9.54 |
EPS Growth | - | - | 28.13% | -29.66% | -41.19% | 20.32% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 124.33 | -91.14 | 43.42 | -105.25 | 36.38 |
Free Cash Flow Per Share | - | 12.43 | -9.11 | 4.34 | -16.37 | 11.20 |
Dividend Per Share | - | - | - | - | 0.100 | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 25.16% | 26.60% | 22.50% | 23.26% | 18.57% | 18.19% |
Operating Margin | -3.86% | -1.38% | 8.28% | 8.30% | 7.28% | 6.90% |
Profit Margin | -4.69% | -3.75% | 5.25% | 5.52% | 4.71% | 4.17% |
Free Cash Flow Margin | - | 14.57% | -9.47% | 6.07% | -13.75% | 4.89% |
EBITDA | 33.18 | 42.46 | 87.78 | 62.18 | 57.72 | 53.32 |
EBITDA Margin | 3.92% | 4.98% | 9.12% | 8.70% | 7.54% | 7.17% |
D&A For EBITDA | 65.83 | 54.28 | 8.07 | 2.85 | 2.01 | 2.02 |
EBIT | -32.65 | -11.81 | 79.71 | 59.34 | 55.72 | 51.3 |
EBIT Margin | -3.86% | -1.38% | 8.28% | 8.30% | 7.28% | 6.90% |
Effective Tax Rate | - | - | 27.48% | 27.42% | 27.11% | 27.11% |
Revenue as Reported | 845.82 | 853.55 | 963.71 | 717.57 | 767.38 | 745.66 |
Advertising Expenses | - | - | 12.94 | 21.33 | 7.7 | 17.74 |